Oscar Arrieta
Oscar Arrieta
Head of the Thoracic Oncology Unit, Instituto Nacional de Cancerología de Mexico
Verified email at - Homepage
Cited by
Cited by
Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancer
H Borghaei, L Paz-Ares, L Horn, DR Spigel, M Steins, NE Ready, ...
New England Journal of Medicine 373 (17), 1627-1639, 2015
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.
Lancet 373 (9674), 1525-1531, 2009
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy …
EB Garon, TE Ciuleanu, O Arrieta, K Prabhash, KN Syrigos, T Goksel, ...
The Lancet 384 (9944), 665-673, 2014
Nivolumab versus docetaxel in previously treated patients with advanced non–small-cell lung cancer: two-year outcomes from two randomized, open-label, phase III trials …
L Horn, DR Spigel, EE Vokes, E Holgado, N Ready, M Steins, ...
Journal of clinical oncology 35 (35), 3924, 2017
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
EE Vokes, N Ready, E Felip, L Horn, MA Burgio, SJ Antonia, OA Frontera, ...
Annals of oncology 29 (4), 959-965, 2018
Five-year outcomes from the randomized, phase III trials checkmate 017 and 057: nivolumab versus docetaxel in previously treated non–small-cell lung cancer
H Borghaei, S Gettinger, EE Vokes, LQM Chow, MA Burgio, ...
Journal of Clinical Oncology 39 (7), 723, 2021
Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin …
O Arrieta, RM Michel Ortega, G Villanueva-Rodríguez, MG Serna-Thomé, ...
BMC cancer 10, 1-7, 2010
Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer
Ó Arrieta, LP Angulo, C Núñez-Valencia, Y Dorantes-Gallareta, ...
Annals of surgical oncology 20, 1941-1948, 2013
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
M Candelaria, D Gallardo-Rincón, C Arce, L Cetina, JL Aguilar-Ponce, ...
Annals of Oncology 18 (9), 1529-1538, 2007
Triple‐negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity
F Lara‐Medina, V Pérez‐Sánchez, D Saavedra‐Pérez, M Blake‐Cerda, ...
Cancer 117 (16), 3658-3669, 2011
Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised …
K Sánchez-Lara, JG Turcott, E Juárez-Hernández, C Nuñez-Valencia, ...
Clinical nutrition 33 (6), 1017-1023, 2014
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study
N van Es, M Di Nisio, G Cesarman, A Kleinjan, HM Otten, I Mahé, IT Wilts, ...
haematologica 102 (9), 1494, 2017
Phase III, randomized trial (CheckMate 057) of nivolumab (NIVO) versus docetaxel (DOC) in advanced non-squamous cell (non-SQ) non-small cell lung cancer (NSCLC).
ASCO Annual Meeting Proceedings J Clin Oncol 33, 2015 (suppl; abstr LBA109 …, 0
Updated frequency of EGFR and KRAS mutations in nonsmall-cell lung cancer in Latin America: the Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)
O Arrieta, AF Cardona, C Martín, L Más-López, L Corrales-Rodríguez, ...
Journal of Thoracic Oncology 10 (5), 838-843, 2015
Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small …
K Sánchez-Lara, JG Turcott, E Juárez, P Guevara, C Núñez-Valencia, ...
Nutrition and cancer 64 (4), 526-534, 2012
Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis
O Arrieta, D Saavedra-Perez, R Kuri, A Aviles-Salas, L Martinez, ...
BMC cancer 9 (1), 1-9, 2009
Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer
E Escobar, TS Rodriguez-Reyna, O Arrieta, J Sotelo
Current vascular pharmacology 2 (4), 385-399, 2004
The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis
O Arrieta, B Cacho, D Morales-Espinosa, A Ruelas-Villavicencio, ...
BMC cancer 7 (1), 1-9, 2007
Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy
K Sánchez-Lara, R Sosa-Sánchez, D Green-Renner, C Rodríguez, ...
Nutrition Journal 9, 1-6, 2010
Lung cancer in never smokers: The role of different risk factors other than tobacco smoking
L Corrales, R Rosell, AF Cardona, C Martin, ZL Zatarain-Barron, O Arrieta
Critical reviews in oncology/hematology 148, 102895, 2020
The system can't perform the operation now. Try again later.
Articles 1–20